Matthew Di Prima

Matthew Di Prima

Auto-generated profile, based on publicly available information

Matthew Di Prima

Division of Applied Mechanics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, United States Food and Drug Administration, Silver Spring, MD, 20993, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2013 in Nature
Verified
Journal Article
Closed access
PDF file
YKYoonseob Kim
Yoonseob Kim
JZJian Zhu
Jian Zhu
BYBongjun Yeom
Bongjun Yeom
MPMatthew Di Prima
Matthew Di Prima
XSXianli Su
Xianli Su
NKNicholas A. Kotov
Nicholas A. Kotov

1 December 2016 in 3D Printing in Medicine
Verified
Journal Article
Open access
PDF file
MPMatthew Di Prima
Matthew Di Prima
JCJames Coburn
James Coburn
DHDavid Hwang
David Hwang
JKJennifer Kelly
Jennifer Kelly
AKAkm Khairuzzaman
Akm Khairuzzaman
LRLaura Ricles
Laura Ricles
Additive manufacturing/3D printing of medical devices is becoming more commonplace, a 3D printed drug is now commercially available, and bioprinting is poised to transition from laboratory to market. Despite the variety of technologies enabling these products, the US Food and Drug Administration (FDA) is charged with protecting and promoting the public health by ensuring these products are safe and effective. To that end, we are presenting the FDA’s current perspective on additive manufacturing/3D printing of medical products ranging from those regulated by the Center for Devices and Radiological Health (CDRH), the Center for Drug Evaluation and Research (CDER), and the Center for Biologics Evaluation and Research (CBER). Each Center presents an overview of the additively manufactured products in their area and the specific concerns and thoughts on using this technology in those product spaces.

1 November 2014 in Polymer
Verified
Journal Article
Closed access
SSSteven Shaffer
Steven Shaffer
KYKejia Yang
Kejia Yang
JVJuan Vargas
Juan Vargas
MPMatthew A. Di Prima
Matthew A. Di Prima
WVWalter Voit
Walter Voit

3 October 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
LRLaura M. Ricles
Laura M. Ricles
JCJames C. Coburn
James C. Coburn
MPMatthew Di Prima
Matthew Di Prima
SOSteven S. Oh
Steven S. Oh
There are a number of key considerations in the U.S. regulatory landscape regarding approval of 3D-printed medical devices and biologics.

12 October 2007 in Smart Materials and Structures
Verified
Journal Article
Closed access
MPM A Di Prima
M A Di Prima
MLM Lesniewski
M Lesniewski
KGK Gall
K Gall
DMD L McDowell
D L McDowell
TST Sanderson
T Sanderson
DCD Campbell
D Campbell

27 April 2011 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JZJian Zhu
Jian Zhu
BSBong Sup Shim
Bong Sup Shim
MPMatthew Di Prima
Matthew Di Prima
NKNicholas A. Kotov
Nicholas A. Kotov